亚洲免费观看高清完整版在线观看-中文字幕制服丝袜-国内外成人免费视频-超碰青娱乐-国产精品二区一区二区aⅴ污介绍-伊人青青草原-国产性猛交xxxx免费看久久-葵司免费一区二区三区四区五区-精品久久久久一区-久久天堂色-越南午夜性猛交xxxx-红桃视频成人在线观看-99精品国产视频-久久黄色成人-日韩电影 中文字幕

Voice-controlled CRISPR / Cas 9 enhanced sonodynamic therapy for hepatocellular carcinoma is a novel strategy using acoustic control of CRISPR / Cas 9 gene editing system to enhance the killing effect of hepatocellular liver cancer (sonodynamic therapy, HCC) by knocking out antioxidant gene NFE2L2 in tumor cells. Acodyndynamic therapy is a non-invasive therapy that uses the combination of ultrasound and drugs to produce harmful reactive oxygen species (reactive oxygen species, ROS) at the tumor site to kill tumor cells. CRISPR / Cas 9 is a technique that enables precise gene editing and can be used to knockout or repair specific genes. Voice-controlled CRISPR / Cas 9 enhanced sonotherapy for hepatocellular carcinoma can use ultrasound stimulation to realize the release and transfection of CRISPR / Cas 9 system at the tumor site, thus reducing the antioxidant capacity of tumor cells and enhancing the effect of sonodynamic therapy.